Novartis STEP Program™ now accepting submissions for proposals that address unmet patient needs in cancer biomarker testing

Tuesday, October 8, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

- STEP Program is available to US-based nonprofit patient advocacy organizations

Novartis Media Relations 

Central media line: +41 61 324 2200

E-mail: media.relations@novartis.com  

Eric Althoff

Kristen Klasey

Novartis US External Communications

Novartis US Communications

+1 646 438 4335 (direct)

+1 862 778 4763 (direct)

eric.althoff@novartis.com  

+1 862 754 1732 (mobile)

kristen.klasey@novartis.com  

Novartis Investor Relations

Central investor relations line: +41 61 324 7944

E-mail: investor.relations@novartis.com

Central

North America

Samir Shah

+41 61 324 7944

Sloan Simpson

+1 212 830 2417

Pierre-Michel Bringer

+41 61 324 1065

Cory Twining

+1 862 278 3258

Thomas Hungerbuehler

+41 61 324 8425

Isabella Zinck

+41 61 324 7188



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store